相似文献
1
CDK6 is a regulator of stem cells "Egr" to wake up.
Blood. 2015 Jan 1;125(1):7-9. doi: 10.1182/blood-2014-11-609230.
2
CDK6 as a key regulator of hematopoietic and leukemic stem cell activation.
Blood. 2015 Jan 1;125(1):90-101. doi: 10.1182/blood-2014-06-584417. Epub 2014 Oct 23.
3
CDK6 levels regulate quiescence exit in human hematopoietic stem cells.
Cell Stem Cell. 2015 Mar 5;16(3):302-13. doi: 10.1016/j.stem.2015.01.017. Epub 2015 Feb 19.
4
CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1-induced T-cell acute lymphoblastic leukemia.
Leukemia. 2016 May;30(5):1033-43. doi: 10.1038/leu.2015.353. Epub 2015 Dec 28.
5
Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1-C/EBPalpha interaction.
EMBO J. 2007 May 2;26(9):2361-70. doi: 10.1038/sj.emboj.7601675. Epub 2007 Apr 12.
6
Hematopoietic development at high altitude: blood stem cells put to the test.
Development. 2015 May 15;142(10):1728-32. doi: 10.1242/dev.121103.
7
Metabolism and the leukemic stem cell.
J Exp Med. 2010 Apr 12;207(4):677-80. doi: 10.1084/jem.20100523. Epub 2010 Apr 5.
8
ZFP36L1 promotes monocyte/macrophage differentiation by repressing CDK6.
Sci Rep. 2015 Nov 6;5:16229. doi: 10.1038/srep16229.
9
Inducible deletion of CDK4 and CDK6 - deciphering CDK4/6 inhibitor effects in the hematopoietic system.
Haematologica. 2021 Oct 1;106(10):2624-2632. doi: 10.3324/haematol.2020.256313.
10
Suppression of normal hematopoiesis during acute leukemias.
Ann N Y Acad Sci. 1991;628:140-7. doi: 10.1111/j.1749-6632.1991.tb17231.x.
引用本文的文献
1
PROTAC-Mediated GSPT1 Degradation Impairs the Expression of Fusion Genes in Acute Myeloid Leukemia.
Cancers (Basel). 2025 Jan 10;17(2):211. doi: 10.3390/cancers17020211.
2
The role of CDK6 in cancer.
Int J Cancer. 2020 Dec 1;147(11):2988-2995. doi: 10.1002/ijc.33054. Epub 2020 May 30.
3
Another piece of the puzzle added to understand t(4;11) leukemia better.
Haematologica. 2019 Jun;104(6):1098-1100. doi: 10.3324/haematol.2018.213397.
4
CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle.
Oncotarget. 2017 Mar 21;8(12):19934-19946. doi: 10.18632/oncotarget.15253.
5
CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation.
Oncogene. 2016 Jun 16;35(24):3083-91. doi: 10.1038/onc.2015.407. Epub 2015 Oct 26.
本文引用的文献
1
CDK6 as a key regulator of hematopoietic and leukemic stem cell activation.
Blood. 2015 Jan 1;125(1):90-101. doi: 10.1182/blood-2014-06-584417. Epub 2014 Oct 23.
2
The cancer drug that almost wasn't.
Science. 2014 Aug 22;345(6199):865-7. doi: 10.1126/science.345.6199.865.
3
Requirement for CDK6 in MLL-rearranged acute myeloid leukemia.
Blood. 2014 Jul 3;124(1):13-23. doi: 10.1182/blood-2014-02-558114. Epub 2014 Apr 24.
4
Concise review: Leukemia stem cells in personalized medicine.
Stem Cells. 2014 Apr;32(4):844-51. doi: 10.1002/stem.1597.
5
Cyclin D as a therapeutic target in cancer.
Nat Rev Cancer. 2011 Jul 7;11(8):558-72. doi: 10.1038/nrc3090.
6
Awakening dormant haematopoietic stem cells.
Nat Rev Immunol. 2010 Mar;10(3):201-9. doi: 10.1038/nri2726.
7
A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis.
Cancer Res. 2009 Feb 1;69(3):810-8. doi: 10.1158/0008-5472.CAN-08-2473. Epub 2009 Jan 20.
8
The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells.
Cell Stem Cell. 2008 Apr 10;2(4):380-91. doi: 10.1016/j.stem.2008.01.015.
9
Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6.
Cell. 2004 Aug 20;118(4):493-504. doi: 10.1016/j.cell.2004.08.002.
Zotero 插件